Taking place on 20–21 November 2026 in Massachusetts, this brings psychiatry into direct conversation with the technologies reshaping it — artificial intelligence, genomics, and precision medicine — through two days of expert-led sessions available both onsite and online.

Psychiatrists, neurologists, psychiatric nurse practitioners, psychologists, researchers, residents, and healthcare leaders from around the world will gather under this years theme to examine how AI-driven diagnostics, pharmacogenomics, and biomarker-based treatment planning are moving from research labs into everyday clinical practice. The hybrid format means no one has to choose between attending and staying close to their patients — delegates joining from the Hilton Garden Inn Boston Canton and those logging in remotely receive identical access to keynotes, scientific sessions, workshops, panel discussions, poster presentations, and all conference materials.